In this respect, it has been demonstrated that drugs used for the treatment of MS patients (e.g. IFN-β) and HIV-infected patients (e.g. zidovudine, indinavir and maraviroc) are able to inhibit the activity and expression of MMP-2 and MMP-9 [14–17]. Here, MMP9 is linked to myeloid sarcoma.